Search for Clinical Trial Results

Sponsored By

Adenocarcinoma of the Appendix - 23 Studies Found

Status Study
Active, not recruiting Study Name: Phase I/IIA Study MK-3475 With Chemotherapy in Patients With Advanced GI Cancers
Condition: Advanced GI Cancer
Date: 2014-10-15
Interventions: Drug: MK-3475 MK-3475 in combination with mFOLFOX6 in a 14
Active, not recruiting Study Name: Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer
Condition:
  • Mucinous Adenocarcinoma of the Colon
  • Muci
    Date: 2012-07-25
    Interventions:
    • Biological: aflibercept 4 mg/k
Withdrawn Study Name: Cholecalciferol(25-[OH]-Vitamin D) in Treating Patients With Colorectal Cancer
Condition:
  • Mucinous Adenocarcinoma of the Colon
  • Muci
    Date: 2011-07-25
    Interventions:
    • Dietary Supplement: cholecalciferol

Terminated Study Name: Paricalcitol, Fluorouracil, and Radiation Therapy in Treating Patients With Rectal Cancer That Can Be Removed in Surgery
Condition:
  • Mucinous Adenocarcinoma of the Rectum
  • Stage IIA Rectal Cancer Date: 2010-09-02
    Interventions:
    • Drug: paricalcitol Given PO
Withdrawn Study Name: Research Study in Patients With Advanced Ovarian Epithelial Cancer
Condition:
  • Ovarian Serous Cystadenocarcinoma
  • Ovarian Serous Surface Papill
    Date: 2003-01-27
    Interventions:
    • Genetic: Comparative Genomic Hybridization

Active, not recruiting Study Name: Intraperitoneal Bortezomib and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Condition:
  • Fallopian Tube Clear Cell Adenocarcinoma
  • Fallopian Tube Endometrioid Adenocarcinoma
    • Date: 2010-02-23
    Interventions:
    • Drug: Bortezomib Given IP
Terminated Study Name: Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III Ovarian Cancer
Condition:
  • Malignant Ovarian Mixed Epithelial Tumor
  • Ovarian Clear Cell Cystadenoc
    Date: 2000-01-28
    Interventions:
    • Drug: Carboplatin Given IV
Completed Study Name: Paclitaxel, Cisplatin, and Topotecan With or Without Filgrastim in Treating Patients With Newly Diagnosed Stage III or Stage IV Epithelial Ovarian Cancer
Condition:
  • Brenner Tumor
  • Ovarian Clear Cell Cystadenocarcinoma
  • Date: 1999-11-01
    Interventions:
    • Drug: paclitaxel Given IV
Active, not recruiting Study Name: Denileukin Diftitox Used in Treating Patients With Advanced Refractory Ovarian Cancer, Primary Peritoneal Carcinoma, or Epithelial Fallopian Tube Cancer
Condition:
  • Fallopian Tube Cancer
  • Ovarian Clear Cell Cystadenocarcinoma Date: 2006-07-26
    Interventions:
    • Biological: denileukin diftitox

Completed Study Name: TLR8 Agonist VTX-2337 and Pegylated Liposomal Doxorubicin Hydrochloride or Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer
Condition:
  • Malignant Ovarian Mixed Epithelial Tumor
  • Ovarian Brenner Tumor
  • Drug: TLR8 Agonist VTX-2337 Gi
<<< Previous | Next >>>